Trial intelligence / Profile preview

Liposomal bupivacaine vs bupivacaine for rotator cuff repair

NCT03587584Phase 4Completed

Sponsor
University of Minnesota
Start
Jul 2018
Primary completion
May 2021
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of liposomal bupivacaine in acute pain, sponsored by University of Minnesota. Primary endpoint: Total Intraoperative Opioids Used. Started Jul 2018; status: completed.

02

Drugs

liposomal bupivacaine
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT03587584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03587584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call